Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04362345
Recruitment Status : Recruiting
First Posted : April 24, 2020
Last Update Posted : April 30, 2020
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Brief Summary:
The aim of the research is to improve patient management by rapidly identifying, based on the terrain and clinical and biological characteristics, those patients likely to present a severe form of ARDS at risk of leading to intensive care

Condition or disease
Covid-19

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Case-Only
Time Perspective: Other
Official Title: Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia in France
Actual Study Start Date : April 9, 2020
Estimated Primary Completion Date : May 17, 2020
Estimated Study Completion Date : May 17, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pneumonia




Primary Outcome Measures :
  1. Identification of risk factors for severity (death or transfer to resuscitation) of Covid-19 infection [ Time Frame: Files analysed retrospectively from March 1st, 2020 to April 15, 2020 will be examined] ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult Patients with Covid-19
Criteria

Inclusion Criteria:

  • Major patient (≥18 years of age)
  • Admitted in March 2020 for confirmed Covid-19 lung disease (nasopharyngeal smear or sputum with SARS-CoV-2 positive PCR).

Exclusion Criteria:

  • Patient who has expressed opposition to participation in the study.
  • Mild forms of infection that do not require hospitalization,
  • Subject under safeguard of justice
  • Subject under guardianship or trusteeship

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04362345


Contacts
Layout table for location contacts
Contact: Yves HANSMANN, MD, PhD 33 3 69 55 09 78 Yves.hansmann@chru-strasbourg.fr
Contact: Saïd CHAYER, PhD, HDR 33 3 88 11 66 90 said.chayer@chru-strasbourg.fr

Locations
Layout table for location information
France
Service des Maladies Infectieuses et Tropicales Recruiting
Strasbourg, France, 67091
Contact: Yves HANSMANN, MD, PhD    33 3 69 55 09 78    Yves.hansmann@chru-strasbourg.fr   
Contact: Charlotte KAEUFFER, MD    33 3 69 55 11 87    Charlotte.kaeuffer@chru-strasbourg.fr   
Principal Investigator: Yves HANSMANN, MD, PhD         
Sub-Investigator: Charlotte KAEUFFER, MD         
Sub-Investigator: François DANION, MD         
Sub-Investigator: Nicolas LEFEBVRE, MD         
Sub-Investigator: Yvon RUCH, MD         
Sub-Investigator: Coralie LE HYARIC, MD         
Sub-Investigator: Antonin HUGEROT, MD         
Sub-Investigator: Olivier HINSCHBERGER, MD         
Sub-Investigator: Joy MOOTIEN, MD         
Sub-Investigator: Nicolas MEYER, MD, PhD         
Sponsors and Collaborators
University Hospital, Strasbourg, France
Layout table for additonal information
Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT04362345    
Other Study ID Numbers: 7773
First Posted: April 24, 2020    Key Record Dates
Last Update Posted: April 30, 2020
Last Verified: April 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Strasbourg, France:
Covid_19
SARS-CoV-2
ARDS
risk factors
infection
Additional relevant MeSH terms:
Layout table for MeSH terms
Pneumonia
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections